Skip to main content
Ophthalmic Surgery, Lasers and Imaging Retina, 2014;45(6):556–561
Published Online:https://doi.org/10.3928/23258160-20141118-11Cited by:19

Abstract

BACKGROUND AND OBJECTIVE:

To determine whether tele-ophthalmology screening for proliferative diabetic retinopathy (PDR) can be cost-saving.

PATIENTS AND METHODS:

Adults with diabetes presenting for routine medical care underwent non-mydriatic fundus photography with remote grading. Direct medical costs were estimated using the Medicare fee schedule in the base case, with Medicaid and commercial insurance rates used for low and high values, respectively. One-way and probabilistic sensitivity analyses were performed.

RESULTS:

Of 99 participants, at least mild retinopathy was found in 24 (24.2%). Urgent consultation was recommended for eight participants (8.1%) for possible vision-threatening diabetic retinopathy, including two participants (three eyes) with PDR. In the base case, screening saved $36 per patient. A Monte Carlo simulation indicated that screening saved a median of $48 per patient.

CONCLUSION:

A substantial burden of diabetic retinopathy was identified, most of which was undiagnosed. In a closed system, tele-ophthalmology screening for PDR is likely to be cost-saving across the range of scenarios explored.

[Ophthalmic Surg Lasers Imaging Retina. 2014;45:556–561.]

  • 1.Kempen JH, O’Colmain BJ, Leske MC, et al.The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004; 122(4):552–563.

    > Crossref MedlineGoogle Scholar
  • 2.Beck RW. The burgeoning public health impact of diabetes: the role of the ophthalmologist. Arch Ophthalmol. 2011; 129(2):225–229.

    > Crossref MedlineGoogle Scholar
  • 3.Javitt JC, Canner JK, Frank RG, Steinwachs DM, Sommer A. Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model. Ophthalmology. 1990; 97(4):483–494; discussion 494-485.

    > Crossref MedlineGoogle Scholar
  • 4.Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996; 124(1 Pt 2):164–169.

    > Crossref MedlineGoogle Scholar
  • 5.Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med. 2010; 27(3):249–256.

    > Crossref MedlineGoogle Scholar
  • 6.Schoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology. 2001; 108(3):563–571.

    > Crossref MedlineGoogle Scholar
  • 7.Paz SH, Varma R, Klein R, Wu J, Azen SP. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology. 2006; 113(8):1372–1377.

    > Crossref MedlineGoogle Scholar
  • 8.Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003; 110(10):1952–1959.

    > Crossref MedlineGoogle Scholar
  • 9.Fong DS, Sharza M, Chen W, Paschal JF, Ariyasu RG, Lee PP. Vision loss among diabetics in a group model Health Maintenance Organization (HMO). Am J Ophthalmol. 2002; 133(2):236–241.

    > Crossref MedlineGoogle Scholar
  • 10.Sharp PF, Olson J, Strachan F, et al.The value of digital imaging in diabetic retinopathy. Health Technol Assess. 2003; 7(30):1–119.

    > Crossref MedlineGoogle Scholar
  • 11.Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen. 2008; 15(1):1–4.

    > Crossref MedlineGoogle Scholar
  • 12.Ng M, Nathoo N, Rudnisky CJ, Tennant MT. Improving access to eye care: teleophthalmology in Alberta, Canada. J Diabetes Sci Technol. 2009; 3(2):289–296.

    > Crossref MedlineGoogle Scholar
  • 13.Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology. 2004; 111(5):1055–1062.

    > Crossref MedlineGoogle Scholar
  • 14.Conlin PR, Fisch BM, Orcutt JC, Hetrick BJ, Darkins AW. Framework for a national teleretinal imaging program to screen for diabetic retinopathy in Veterans Health Administration patients. J Rehabil Res Dev. 2006; 43(6):741–748.

    > Crossref MedlineGoogle Scholar
  • 15.Sanchez CR, Silva PS, Cavallerano JD, Aiello LP, Aiello LM. Ocular telemedicine for diabetic retinopathy and the Joslin Vision Network. Semin Ophthalmol. 2010; 25(5–6):218–224.

    > Crossref MedlineGoogle Scholar
  • 16.Ahmed J, Ward TP, Bursell SE, Aiello LM, Cavallerano JD, Vigersky RA. The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care. 2006; 29(10):2205–2209.

    > Crossref MedlineGoogle Scholar
  • 17.Li HK, Horton M, Bursell SE, et al.Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011; 17(10):814–837.

    > Crossref MedlineGoogle Scholar
  • 18.Bresnick GH, Mukamel DB, Dickinson JC, Cole DR. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy. Ophthalmology. 2000; 107(1):19–24.

    > Crossref MedlineGoogle Scholar
  • 19.Zimmer-Galler I, Zeimer R. Results of implementation of the DigiScope for diabetic retinopathy assessment in the primary care environment. Telemed J E Health. 2006; 12(2):89–98.

    > Crossref MedlineGoogle Scholar
  • 20.Romero P, Sagarra R, Ferrer J, Fernandez-Ballart J, Baget M. The incorporation of family physicians in the assessment of diabetic retinopathy by nonmydriatic fundus camera. Diabetes research and clinical practice. 2010; 88(2):184–188.

    > Crossref MedlineGoogle Scholar
  • 21.Olayiwola JN, Sobieraj DM, Kulowski K, St Hilaire D, Huang JJ. Improving diabetic retinopathy screening through a statewide tele-medicine program at a large federally qualified health center. J Health Care Poor Underserved. 2011; 22(3):804–816.

    > Crossref MedlineGoogle Scholar
  • 22.Germain N, Galusca B, Deb-Joardar N, et al.No loss of chance of diabetic retinopathy screening by endocrinologists with a digital fundus camera. Diabetes Care. 2011; 34(3):580–585.

    > Crossref MedlineGoogle Scholar
  • 23.Garg S, Jani PD, Kshirsagar AV, King B, Chaum E. Telemedicine and Retinal Imaging for Improving Diabetic Retinopathy Evaluation. Arch Intern Med. 2012:1–2.

    > Google Scholar
  • 24.Salti H, Cavallerano JD, Salti N, et al.Nonmydriatic retinal image review at time of endocrinology visit results in short-term HbA1c reduction in poorly controlled patients with diabetic retinopathy. Telemed J E Health. 2011; 17(6):415–419.

    > Crossref MedlineGoogle Scholar
  • 25.Whited JD, Datta SK, Aiello LM, et al.A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health. 2005; 11(6):641–651.

    > Crossref MedlineGoogle Scholar
  • 26.James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000; 320(7250):1627–1631.

    > Crossref MedlineGoogle Scholar
  • 27.Aoki N, Dunn K, Fukui T, Beck JR, Schull WJ, Li HK. Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population. Diabetes Care. 2004; 27(5):1095–1101.

    > Crossref MedlineGoogle Scholar
  • 28.Center UoW-MPRCFPR. Modified 3-Standard Field Digital Color Fundus Photography (3M-D). 2012; http://eyephoto.ophth.wisc.edu/photography/PDFs/3M-D.pdf. Accessed February 3, 2013.

    > Google Scholar
  • 29.Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol. 2011; 129(4):435–444.

    > Crossref MedlineGoogle Scholar
  • 30.Shotliff K, Duncan G. Diabetic retinopathy: summary of grading and management criteria. Pract Diab Int. 2006; 23(9):418–420.

    > CrossrefGoogle Scholar
  • 31.Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984; 102(4):527–532.

    > Crossref MedlineGoogle Scholar
  • 32.Ferris Fl. How effective are treatments for diabetic retinopathy?JAMA: The Journal of the American Medical Association. 1993; 269(10):1290–1291.

    > Crossref MedlineGoogle Scholar
  • 33.Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000; 17(5):479–500.

    > Crossref MedlineGoogle Scholar
  • 34.Smiddy WE. How will the digital age enhance the evaluation of diabetic retinopathy?Am J Ophthalmol. 2012; 154(3):425–426.

    > Crossref MedlineGoogle Scholar
  • 35.Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1976; 81(4):383–396.

    > MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×